Cargando…

Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor

Background: Thrombin generation (TG), platelet function and circulating endothelial progenitor cells (EPCs) have an important role in the pathophysiology of coronary artery disease (CAD). To date, the effect of novel P2Y(12) inhibitors on these aspects has mostly been studied in the sub-acute phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiessman, Maya, Kheifets, Mark, Schamroth Pravda, Nili, Leshem Lev, Dorit, Ziv, Eti, Kornowski, Ran, Spectre, Galia, Perl, Leor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811044/ https://www.ncbi.nlm.nih.gov/pubmed/36598739 http://dx.doi.org/10.1007/s11239-022-02759-6

Ejemplares similares

Reticulated Platelets and Their Relationship with Endothelial Progenitor Cells during the Acute Phase of ST-Elevation Myocardial Infarction
por: Schamroth Pravda, Nili, et al.
Publicado: (2022)

Coronary Stenosis Physiology and Novel Technologies
por: Pravda, Nili Schamroth, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic
por: Pravda, Nili Schamroth, et al.
Publicado: (2020)

Dysfunctional endothelial progenitor cells in patients with Hodgkin’s lymphoma in complete remission
por: Wiessman, Maya, et al.
Publicado: (2018)

Clinical considerations during spontaneous coronary artery dissection in the post-partum period: a case report
por: Schamroth Pravda, Nili, et al.
Publicado: (2023)

Coronary Artery Disease in Women: A Comprehensive Appraisal
por: Schamroth Pravda, Nili, et al.
Publicado: (2021)

Management and outcome across the spectrum of high‐risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk‐score for secondary prevention
por: Grinberg, Tzlil, et al.
Publicado: (2021)

Temporal trends in the pre-procedural TIMI flow grade among patients with ST- segment elevation myocardial infarction – From the ACSIS registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2021)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

5 Year Outcomes of Patients With Aortic Structural Valve Deterioration Treated With Transcatheter Valve in Valve – A Single Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2021)

Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2022)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
por: Alexopoulos, Dimitrios, et al.
Publicado: (2013)

Effect of vitamin D on endothelial progenitor cells function
por: Hammer, Yoav, et al.
Publicado: (2017)

P979: EXOSOMES IN POLYCYTHEMIA VERA: “MINI PLATELETS“ WITH THROMBOGENIC POTENTIAL
por: Abulafia, A., et al.
Publicado: (2022)

Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous
por: Schamroth Pravda, Nili, et al.
Publicado: (2022)

Tricuspid Structural Valve Deterioration Treated with a Transcatheter Valve-in-Valve Implantation: A Single-Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2022)

Transcatheter Interventions for Atrioventricular Dysfunction in Patients with Adult Congenital Heart Disease: An International Case Series
por: Schamroth Pravda, Nili, et al.
Publicado: (2023)

Long‐Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Cassese, Salvatore, et al.
Publicado: (2020)

Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients
por: Gager, Gloria M., et al.
Publicado: (2020)

Complex Catheter-Based Structural Heart Reconstruction in a Patient With Tricuspid Atresia and Björk Palliative Conduit
por: Schamroth Pravda, Nili, et al.
Publicado: (2021)

Management and outcomes over time of acute coronary syndrome patients at particularly high cardiovascular risk : the ACSIS registry-based retrospective study
por: Grinberg, Tzlil, et al.
Publicado: (2022)

Noninvasive Hemodynamic Evaluation Following TAVI for Severe Aortic Stenosis
por: Grinberg, Tzlil, et al.
Publicado: (2023)

Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
por: Grossman, Shelly Meron, et al.
Publicado: (2021)

Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
por: Alexopoulos, Dimitrios, et al.
Publicado: (2015)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

The Scattering of Gold Nanorods Combined with Differential Uptake, Paving a New Detection Method for Macrophage Subtypes Using Flow Cytometery
por: Chakraborty, Ruchira, et al.
Publicado: (2020)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
por: Dai, Lulu, et al.
Publicado: (2022)

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023)

Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
por: Yildirim, Mustafa, et al.
Publicado: (2023)

Management of ascending aorta perforation during transseptal puncture for left atrial appendage closure: a case report
por: Schamroth Pravda, Nili, et al.
Publicado: (2021)

Self-Reported Mental and Physical Measures in Adult Fontan Patients
por: Schamroth Pravda, Nili, et al.
Publicado: (2022)

Percutaneous Atrio-Ventricular Valve Interventions: Contemporary Advances and Remaining Challenges
por: Perl, Leor, et al.
Publicado: (2022)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
por: Kim, Yuri, et al.
Publicado: (2023)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
por: Olechowski, Bartosz, et al.
Publicado: (2016)

Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis
por: Wen, Mingxiang, et al.
Publicado: (2020)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oaavips57a4pg9v0nhu8s55nsc